Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
13 hedge funds and large institutions have $4.87M invested in Genetic Technologies Ltd. in 2015 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
2,928% more capital invested
Capital invested by funds: $161K → $4.87M (+$4.71M)
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
160% more funds holding
Funds holding: 5 → 13 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.42M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$544K |
| 3 |
Millennium Management
New York
|
+$223K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$167K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$61.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$27K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $3.43M | +$2.42M | +29,599 | +1,007% |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $700K | +$544K | +6,650 | New |
|
|
3
Millennium Management
New York
| $287K | +$223K | +2,722 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $215K | +$167K | +2,037 | New |
|
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $79K | +$61.3K | +750 | New |
|
6
Jane Street
New York
| $71K | +$55.1K | +674 | New |
|
|
VKH
7
Virtu KCG Holdings
New York
| $60K | +$30.2K | +369 | +187% |
|
8
Morgan Stanley
New York
| $15K | +$11.5K | +141 | New |
|
9
UBS Group
Zurich,
Switzerland
| $10K | +$7.44K | +91 | New |
|
10
Creative Planning
Overland Park,
Kansas
| $4K | +$3.52K | +43 | New |
|
11
Bank of America
Charlotte,
North Carolina
| $2K | +$1.47K | +18 | New |
|
|
AIG
12
American International Group
New York
| $1.84K | +$1.47K | +18 | New |
|
|
TDC
13
Thompson Davis & Co
Richmond,
Virginia
| – | -$27K | -690 | Closed |
|
|
14
Ameriprise
Minneapolis,
Minnesota
| – | -$9K | -229 | Closed |
|
15
Citigroup
New York
| – | +$163 | +2 | New |
|
GENE Hedge Fund Activity: Q1 2015 in Review
13 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2015, worth a combined $4.87M — up 2,928% from $161K a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GENE positions and 2 closed out — a net gain of 9 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $2.42M. The largest seller was Thompson Davis & Co, exiting entirely with an estimated $27K sold.
- 13 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2015, up from 5 in Q4 2014.
- Funds reported $4.87M of Genetic Technologies Ltd. stock for Q1 2015, up 2,928% quarter-over-quarter.
- 11 funds opened new Genetic Technologies Ltd. positions in Q1 2015 and 2 closed out, a net change of +9 holders.
- The largest Genetic Technologies Ltd. buyer in Q1 2015 was Renaissance Technologies, an estimated $2.42M added.
- The largest Genetic Technologies Ltd. seller in Q1 2015 was Thompson Davis & Co, an estimated $27K sold.
Based on aggregated 13F filings for Q1 2015.